Experienced in Ocular Toxoplasmosis

Hans R. Van Vlierberghe

Gent, VLG, BE 
Experienced in Ocular Toxoplasmosis
Gent, VLG, BE 
OverviewLocationsClinical Research

Overview

Hans Van Vlierberghe practices in Gent, Belgium. Mr. Van Vlierberghe is rated as an Experienced expert by MediFind in the treatment of Ocular Toxoplasmosis. His top areas of expertise are Liver Cancer, Cirrhosis, Hepatitis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 221 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Ocular Toxoplasmosis.

Gender
Male

Locations

Gent, VLG, Belgium
Other Locations
Ziekenhuis Oost Limburg
Genk, VLG, Belgium
Brussels, BRU 1090, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A first-time-in Human (FTIH), Phase I/II, Randomized, Multi-centric, Single-blind, Controlled Dose-escalation Study to Evaluate the Reactogenicity, Safety, Immunogenicity and Efficacy of GSK Biologicals' HBV Viral Vector Vaccines Given in a Prime-boost Schedule With Sequential or Co-administration of Adjuvanted Proteins Therapeutic Vaccine (GSK3528869A) in Chronic Hepatitis B Patients (18-65 Years Old) Well Controlled Under Nucleo(s)Tide Analogue (NA) Therapy
A first-time-in Human (FTIH), Phase I/II, Randomized, Multi-centric, Single-blind, Controlled Dose-escalation Study to Evaluate the Reactogenicity, Safety, Immunogenicity and Efficacy of GSK Biologicals' HBV Viral Vector Vaccines Given in a Prime-boost Schedule With Sequential or Co-administration of Adjuvanted Proteins Therapeutic Vaccine (GSK3528869A) in Chronic Hepatitis B Patients (18-65 Years Old) Well Controlled Under Nucleo(s)Tide Analogue (NA) Therapy
Enrollment Status: Terminated
Publish Date: November 29, 2024
Intervention Type: Biological, Drug
Study Drugs: ChAd155-hIi-HBV, HBc-HBs/AS01B-4, MVA-HBV
Study Phase: Phase 1/Phase 2
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
Enrollment Status: Completed
Publish Date: December 15, 2022
Intervention Type: Procedure
Study Phase: Phase 1
Randomized Controlled Trial Comparing Kaffes Stent With Plastic Prosthesis in the Treatment of Anastomotic Biliary Strictures Post Orthotopic Liver Transplantation
Randomized Controlled Trial Comparing Kaffes Stent With Plastic Prosthesis in the Treatment of Anastomotic Biliary Strictures Post Orthotopic Liver Transplantation
Enrollment Status: Completed
Publish Date: December 15, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
Enrollment Status: Completed
Publish Date: June 29, 2022
Intervention Type: Drug
Study Phase: Phase 2
Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis
Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis
Enrollment Status: Terminated
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

221 Total Publications

The burden of ascites in cirrhosis.
The burden of ascites in cirrhosis.
Journal: Acta clinica Belgica
Published: May 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Vlierberghe's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 11 Advanced Conditions
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile